The Small Biotech Scaring Big Pharma
There's one tiny biotech on the verge of a breakthrough dementia treatment...
Biogen, the only biotech to get a new Alzheimer's drug approved in the past 20 years, made a $1 billion investment in this company.
"The Buck Stops Here,"
Thank you for subscribing to Insider Trades Daily, which covers the most recent insider buying and selling activity from Wall Street CEO's, CFO's, COO's and other insiders.
This message is a paid advertisement sent on behalf of Behind the Markets, a third-party advertiser of InsiderTrades.com and MarketBeat.
If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.
If you no longer wish to receive email from InsiderTrades.com, you can unsubscribe.
© 2006-2023 American Consumer News, LLC dba MarketBeat.
326 E 8th St #105, Sioux Falls, SD 57103. United States. Today's Bonus Content: Stock-picking System Predicts Top Stocks of 2023
This message is a paid advertisement sent on behalf of Behind the Markets, a third-party advertiser of InsiderTrades.com and MarketBeat.
If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.
If you no longer wish to receive email from InsiderTrades.com, you can unsubscribe.
© 2006-2023 American Consumer News, LLC dba MarketBeat.
326 E 8th St #105, Sioux Falls, SD 57103. United States.
No comments:
Post a Comment